Electrophysiology Market – Increasing Cardiac Ablation Procedural Volume

1
Global Electrophysiology Market Growth is set to
be driven by the Increasing Cardiac Ablation
Procedural Volume
2
Electrophysiology (EP) is a test used to diagnose
abnormal heart rhythm or arrhythmias. It helps in
evaluating the electrical activity of the heart
by inserting a catheter into blood vessels that
enter heart and then measuring the electrical
activity through wire electrodes. EP ablation
catheters, EP laboratory devices, EP diagnostic
catheters, and EP access devices are just a few
examples of the various types of EP
products. The Global Electrophysiology
Market valued at 6.7 billion (2021) is set to
witness a growth rate of 12 in the next 5 years.
The global electrophysiology market is being
driven by a number of key factors, including an
increase in the volume of cardiac ablation
procedures, a quick increase in the geriatric
population to target diseases, a growing number
of electrophysiology labs, the development of
technologically advanced products by market
players, and huge investments and funding from
government bodies and market players. New
product development and commercialization to fuel
the Electrophysiology Market demand Technological
advancements in terms of new product development
tend to provide competitive edge to manufacturers
and therefore, major players are continuously
focusing on investing in research activities for
new product development and increasing their
geographic reach to strengthen their positions in
this high growth market.
3

• Below is a list of some recent developments
• In May 2022, CathVision received the US Food and
  Drug Administration (FDA) clearance for its
  ECGenius electrophysiology recording system
  offering high-fidelity, low-noise, cardiac
  electrograms, which helps electrophysiologists
  improve diagnosis and treatment of complex atrial
  arrhythmias such as atrial fibrillation (AF)
• In February 2022, Medtronic received the US FDA
  expanded approval for its Freezor and Freezor
  Xtra Cardiac Cryoablation Focal Catheters for the
  treatment of pediatric atrioventricular nodal
  reentrant tachycardia (AVNRT)
• In January 2022, Abbott received the US FDA
  clearance for its EnSite X EP System featuring
  EnSite Omnipolar Technology (OT), designed for
  the treatment of cardiac arrhythmias efficiently
  by creating three-dimensional maps of the heart
• In June 2021, Siemens Healthineers received CE
  mark for its ACUSON AcuNav Volume ICE Catheter
  that helps in improving procedural efficiency for
  structural heart procedures due to reduction of
  general anesthesia
• Explore Premium Report on Electrophysiology
  Market _at_ https//meditechinsights.com/electrophysi
  ology-market/
• Growing number of electrophysiology labs to boost
  adoption the Adoption of Electrophysiology Market
• Increasing prevalence of atrial fibrillation and
  other target diseases drives the adoption of
  electrophysiology procedures across the globe.
  Both public and private organisations are
  continuously concentrating on creating EP labs
  and growing their services to provide patients
  with advanced treatment options.

4

• In February 2022, Ramesh Hospitals
  (India) launched an advanced cardiac
  electrophysiology lab in Vijayawada, India with
  an aim to help and treat patients through
  advanced therapies such as RF ablation
• In February 2022, Catholic Health (US) launched
  St. Francis Heart Center (SFHC) at its St.
  Catherine of Siena Hospital (SCSH) in Smithtown,
  US, for the treatment of patients with acute
  chest pain
• In January 2022, Pulse Heart Institute
  (US) partnered with Summit Health Oregon (SHO),
  one of the largest independent multispecialty and
  physician-led medical group in Central Oregon, to
  launch EP services through the Heart Rhythm COE
• Key strategies adopted by leading players
  operating in Electrophysiology Market
• Leading players in the electrophysiology market
  have accepted acquisitions as key growth strategy
  to expand their product offerings and to develop
  advanced products.
• Some of these advances are listed below-
• In January 2022, Medtronic plc entered into an
  agreement to acquire Affera, Inc. offering
  solutions for cardiac arrhythmias. With this
  acquisition, Medtronic intends to advance its
  electrophysiology by entering into additional EP
  segments, such as mapping and navigation
• In January 2022, H-CYTE, Inc. entered into a
  letter of intent to acquire Catheter Precision,
  Inc., a company focussed on developing advanced
  cardiac electrophysiology products
• In June 2021, Boston Scientific
  Corporation exercised its option and acquired
  remaining shares of Farapulse, Inc., to
  complement its existing EP portfolio by including
  FARAPULSE Pulsed Field Ablation (PFA) System
• In January 2021, Haemonetics Corporation entered
  into an agreement to acquire Cardiva Medical,
  Inc., a manufacturer of vascular closure system
  used during electrophysiology procedures

5
Competitive Landscape Analysis of
Electrophysiology Market The global
electrophysiology market is marked by the
presence of key players such as Abbott
Laboratories (US) Medtronic plc (Ireland)
Boston Scientific Corporation (US) BIOTRONIK SE
Co. KG (Germany) Johnson Johnson (US) and
others. For More Detailed Insights, Contact Us
_at_ https//meditechinsights.com/contact-us/ About
Medi-Tech Insights Medi-Tech Insights is a
healthcare-focused business research insights
firm. Our clients include Fortune 500 companies,
blue-chip investors hyper-growth start-ups. We
have completed 100 projects in Digital Health,
Healthcare IT, Medical Technology, Medical
Devices Pharma Services. Contact Ruta
Halde Associate, Medi-Tech Insights 32 498 86 80
79 info_at_meditechinsights.com